chrisvoncsefalvay/vaers-outcomes huggingface dataset:
SWOLLEN EYES; ITCHINESS; EDEMA of legs; RASH on face and legs; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (SWOLLEN EYES), PRURITUS (ITCHINESS), OEDEMA PERIPHERAL (EDEMA of legs) and RASH (RASH on face and legs) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced EYE SWELLING (SWOLLEN EYES), PRURITUS (ITCHINESS), OEDEMA PERIPHERAL (EDEMA of legs) and RASH (RASH on face and legs). At the time of the report, EYE SWELLING (SWOLLEN EYES), PRURITUS (ITCHINESS), OEDEMA PERIPHERAL (EDEMA of legs) and RASH (RASH on face and legs) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Patient reported using diphenhydramine for treating her symptoms.
Patient complained having palpitation, sweating in both palms, and pressure in chest/some difficulty with breathing. Patient agreed to call 911 and go to the hospital. Paramedics came and transported her to the hospital. Patient stated she had history of palpitation and anxiety
Moderna vaccine was administered outside - reported by patient  J96.00 ACUTE RESPIRATORY FAILURE 3/3/2022 ACQUIRED MULTIPLE RENAL CYSTS J96.00 ACUTE RESPIRATORY FAILURE 3/3/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED
Myalgia, CoughWheeze & NauseaVomiting Narrative: Myalgia, Nausea, cough; recovered
Vaccination Error/Vaccine Misadministered  Patient was registered for Pfizer vaccination on MyTurn however in the clinic was given Moderna. Vaccine was administered by an MA here in the clinic. No symptoms during  the time of the administration, during the wait period for 15 minutes and currently. I verified by calling mother of patient today 7/9/21 whom denies any symptoms or concerns currently.
muscle weakness/fatigue (approx. 6 hours through approx. 36 hours) chills (approx. 15 hours through approx. 18 hours) fever (2+ degrees above normal) (approx. 18 hours through approx. 36 hours) general fatigue (approx. 18 hours through approx. 36 hours) headache (approx. 12 hours through approx. 36 hours) abdominal cramping (approx. 15 hours through approx. 18 hours) joint pain (left hand) (approx. 15 hours through approx. 24 hours)
The patient came in to get her flu vaccine but had already received it on 9.28.2021. She received another flu vaccine on 10.16.2021.
Chills on the evening of injection.  The next day 1/26/21 - 100.2 fever, headache, body aches- 600mg of ibuprofen taken once around 8 AM.  Fever and body aches improved post ibuprofen, headache persisted.  Evening of 1/26/21 fever seemed to return at 99.1 but resolved the morning of 1/27/21.  Injection site reaction of warm, red, slightly raised bump noted on the AM of 1/27/21- no action taken at this time
Okay first hours. Started feeling dizzy. Went to sleep, Woke up next morning went shopping, started with dizziness again. On the way back home pulled into carport and bumped into the house. She sideswiped everything. Blacked out as she was backing into the driveway. Hit the house several times. She has no recollection of this. Totaled the car, house has to be repaired.  Ribs are in pain from accident.
7/12 Presented with erythema and warmth at Td site. States after getting vaccine, developed fever to 101 with pain, and warmth at injection site. Advised by MD to use Aleve and warm compresses.
monovalent COVID-19 vaccine was administered as a booster shot instead of a bivalent. Patient did not have any adverse events or outcome
I had a lot of fatigue after my vaccine which is common for me after an influenza vaccine (which is why I no longer get them) and common for others with chronic fatigue syndrome for the fatigue to last longer than for other people. I have hypothyroidism and my antithyroglobulin and anti TPO antibodies have been tested two or three times over the past 3 years or so. They've always been either in range or very close to the bottom of the range. In February of 2019 TgAb was 6.4 IU/mL and TPO was 12 IU/mL . When I was recently (I used this for the vaccine reaction date) tested TgAb had jumped to 145 IU/mL and TPO was down to 1.0 IU/mL. I have no idea why one would jump and one would go down, but I mentioned it to a person following up with me from the CDC about my vaccine and they felt that I should report it to VAERS in case others had a similar experience or to help better understand how it might affect autoimmunity. I had a thyroid ultrasound yesterday to rule out any issues with a hot nodule although no nodules are palpable.
sx began approx 5hr p/vax rt arm became very sore w/some swelling & redness progressed to generalized muscle pain on rt side including stiff neck;sx subsided w/in 24hr;
Administered FluVac 0.5 ml IM. Within 2-4 minutes lost consciousness, stopped breathing, immediate administrative of .3 cc epinephrine. Transported to Hosp by Ambulance cl recovered. Without further treatment and returned home 11/01/2001.
This spontaneous report as received from a physician via a company representative refers to a 3 year old male patient with no pertinent medical history and drug reactions/allergies. On an unknown date the patient was vaccinated with a dose of (Oka/Merck) VARIVAX (lot #, expiration date, dose and route were unknown). No concomitant therapies were reported. The patient was diagnosed with chicken pox, after receiving (Oka/Merck) VARIVAX. Additional information has been requested.
Patient called the pharmacy the morning after receiving her first dose reporting symptoms of severe projectile vomiting, nausea, and fever. Patient reported that she required hospitalization to treat her symptoms.
I had a bad cough that would not go away at all.  This lasted about 3 weeks.  I went to the doctor about this.  She gave me medicine for it.
Pfizer shots 02/03/2021, 03/04/2021  03/18/2021 tiny bumps started appearing on my lips. I had more every day through 03/26/21 until both lips were covered in bumps. The bumps were like tiny sores, very itchy and slight weeping. During the same period of time, the roof of my mouth hurt and itched really bad as if I?d had a terrible burn, but I couldn?t recall burning it.  Period started 3/25/21. 3/26/21 I was prescribed 4 doses of antivirals and the bumps went away within a few days.   4/18/21 rough spots appeared on my lips. 4/19/21 tiny bumps appeared just like the ones a month prior.  Was prescribed antivirals 3 doses per day (21 doses total), 4/19-4/26/21. The bumps went away. Period started 4/24/21.  After last dose of antivirals on 4/26/21 tiny bumps appeared and lasted four days until 4/30/21.  5/23/21 I had numerous bumps on my shoulders, arms, and face. It looked like acne pimples or bug bites. 5/24/21-5/25/21 the bumps multiple and became inflamed and looked more like hives or a rash. Again, the roof of my mouth hurt and itched really bad as if I?d had a terrible burn, but I couldn?t recall burning it. Period started 5/24/21. 5/28/21 I went to urgent care because the bumps were still multiplying and very inflamed. I was diagnosed with poison ivy. Received a steroid shot and pills to take twice daily for 15 days to reduce itching. Inflammation started to improve soon after the shot. Spread of bumps slowed, but I continued seeing new spots every day or every few days. I continued to feel incredibly itchy constantly until 6/3/21. 6/3/21 I started having one hour or longer without itching. 6/7/21 stomach rash appeared and a 3 inch red line of little bumps on my face.
16 mos old child, received her HIB and MMR on the Rt thigh, developed red, hard swelling one week after the date of injections. Subsided gradually on its own. She had HIB before with no reactions.
This spontaneous report as received from a registered nurse refers to two patients of unknown age and gender. On 04-OCT-2013, the patients were vaccinated with a dose of PROQUAD (Merck) (lot #J004174, expiration date 08-OCT-2014, dose, frequency, route and indication not reported). The vaccine was stored improperly at temperatures up to 21F from 01-JUL-2013 to 08-OCT-2013. On 08-OCT-2013, the vaccine was discarded. No adverse effects were reported. It was unspecified if the patients had sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Contracted covid last week; This spontaneous case was reported by an other health care professional and describes the occurrence of SUSPECTED COVID-19 (Contracted covid last week) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SUSPECTED COVID-19 (Contracted covid last week). At the time of the report, SUSPECTED COVID-19 (Contracted covid last week) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication list was not provided.  Treatment information was not provided.  It was reported that the patent contracted COVID-19 last week, felt fine now and was still quarantined. The patient also reported that none of the people that was in contact with the patient had symptoms and tested negative.Lack of efficacy, Covid after 2 shots and the booster was reported.  Company Comment: This case concerns a patient of unknown age and gender, with no relevant medical history, who experienced the unexpected non-serious AESI event of Suspected COVID-19. The event occurred on an unknown date after the third dose of mRNA-1273 vaccine. It was reported that the patient contracted COVID-19 last week, felt fine now and was still quarantined. The patient also reported that none of the people that was in contact with the patient had symptoms and tested negative. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This case concerns a patient of unknown age and gender, with no relevant medical history, who experienced the unexpected non-serious AESI event of Suspected COVID-19. The event occurred on an unknown date after the third dose of mRNA-1273 vaccine. It was reported that the patient contracted COVID-19 last week, felt fine now and was still quarantined. The patient also reported that none of the people that was in contact with the patient had symptoms and tested negative. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Right lat thigh approx 5 cm circular eryth plaque without central puncture lesion; non-tender. No neuro prob's. T 98.6
rash; thrombocytopenia; This case was reported by a consumer via interactive digital media and described the occurrence of rash in a 5-day-old male patient who received Hepatitis B vaccine for prophylaxis.   On an unknown date, the patient received Hepatitis B vaccine. On an unknown date, less than a day after receiving Hepatitis B vaccine, the patient experienced rash (serious criteria death and hospitalization) and thrombocytopenia (serious criteria death, hospitalization and GSK medically significant). On an unknown date, the outcome of the rash and thrombocytopenia were fatal. The reported cause of death was rash and thrombocytopenia.   It was unknown if the reporter considered the rash and thrombocytopenia to be related to Hepatitis B vaccine.  Additional details were provided as follows: Within 12 hours after vaccination, the patient had a rash and within 24 hours severe thrombocytopenia set in and he was in fatal state from then on. The patient suffered nearly his entire life. His parent's literally lived at the hospital and never left his side. The patient lived for 47 days after receiving the vaccine. No doctors, nurses, staff would even consider the vaccination as the source.; Reported Cause(s) of Death: Rash; Thrombocytopenia
Pt recvd vax 20MAY92 & had usual redness & sl temp 21MAY & 22MAY; 23MAY ok; 24-26MAY t013.7; 28MAY rash devel, speckled, red-raised on abdomen; also behind ears & a little on back, shoulder & arms; called MD for runny nose;
This spontaneous report was received from a pharmacist, concerning a patient of an unknown age and gender. There were no concurrent conditions, medical history, drug reactions or allergies or concomitant medications reported. On 31-MAY-2017, the patient was vaccinated with an expired dose of VAQTA injection (dose, frequency and route were not reported) lot # M016191 with expiration date of 26-MAY-2017, for prophylaxis. No adverse effects were reported. Additional information has been requested.
This spontaneous report was received from a healthcare worker referring to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 21-APR-2015, the patient was vaccinated with an expired dose of M-M-R II, subcutaneously, (lot # J006135, expiry date 17-APR-2015). No adverse experience reported. Additional information has been requested.
Post-shot in the waiting room ----Within minutes my throat began to close and it became hard to swallow. Once i removed my mask  for better breathing, chest became tight and swallowing became extremely difficult. Breathing quickly became challenging. I flagged attendant about my symptoms then quickly rushed to the back patient room. I explained this reaction is similar to an asthma attack - and attempted to use my recuse inhaler.  I used my rescue inhaler about 6-8 times.  I was offered water and to sit down to focus on breathing. Breathing returned to normal after waiting the full 30mins. I immediately scheduled a follow-up with my PCP to discuss my experience.
Mom reported later in the evening around 10pm on 07/08/20 her son vomited X 3 episodes and had an elevated temperature of 102F.  Mom stated she rotated between Tylenol and Motrin which seemed to lower temp, but the next day son had a temperature of 106.4.  She stated she took son to pediatrician when temp remained elevated.  Mom stated she took son to Hospital for lab work.  She reported WBC count "over 20,000" and CRP "34."  Mom denied son had diarrhea, cough, seizure.   She was referred to a rheumatologist for possible "periodic fever syndrome...familial mediterranean fever syndrome."
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 01/11/21Lot#012L20A 2nd dose 02/06/21,lot#012M20A Diagnosed covid positive:08/08/21 Symptom onset:08/07/21 Exposure: Symptoms:muscle ache,nasal congestion
Information has been received from a 67 year old female with allergic reaction to ERYTHROMYCIN, KEFLEX, sulfa, FLAGYL, BUTALBITAL, aspirin and TOLCIN and a history of shingles and "stomach issues" who on 12-DEC-2008 was vaccinated with ZOSTAVAX (Oka/Merck) (lot number, route and site not reported).  There was no concomitant medication.  On 13-DEC-2008 the patient developed cold sores all over her lips, blotches on her face (cheeks and forehead) and welts on her back.  The patient saw her physician and a nurse practitioner.  The nurse practitioner prescribed ACYCLOVIR.  However, within one day of taking ACYCLOVIR the patient had stomach pains so she had to stop.  The nurse practitioner then switched her to VALTREX.  The patient recently saw her chiropractor and as he was doing a treatment to her back he told her the welts on her back were chickenpox.  The patient had also been having severe itching.  The patient had been using BENADRYL and CLARITIN.  The patient had used some ZOVIRAX cream that seemed to help clear up welts.  The patient took VALTREX for 2 weeks and stopped.  The patient was currently taking lysine once a day.  The patient said each day the welts seemed to "morph" and changed but the patient was getting better.  The patient said, "They look like giant measles under the skin."  This is one of several reports received the same source.  Additional information has been requested.
Tdap, Varicella, MCV4, & Gardasil were completely administered at approximately 1:50 p.m. on 7/28/09; When the family was checking out at the clerk's window, the patient told her mother she felt weak.  The patient leaned against the wall and the mother assisted her to the floor.  When the nurse arrived at the front, the patient was awake, alert, & oriented.  She was clammy and c/o nausea.  The nurse assisted her to the bathroom and the patient sat down.  B/P was 72/46, Respirations 14, regular;  Skin cool and damp, pale.  After about 15 minutes, patient began feeling better, color had returned.
Narrative: COVID infection following COVID vaccine series 04/15. Moderna, dose #1 05/13, Moderna, dose #2 08/08 pt cc: cough,rhinorrhea, exposure: unknown 08/09-08/18 Pt symptoms continue 08/13 COVID swab, result: detected
Friday, I felt like a sinus or bronchitis infection - though it was allergies bought COVID home test, that Saturday on 21AUG2021. I couldn't smell my pork chop dinner. Tested positive for COVID. Husband was negative, Went to Urgent care and was positive. Normally I do lose my taste and smell for all my sinus infection. It was like a common cold and no fever.
Narrative: 82 yo gentleman with hx of CAD s/p MI, s/p LAD stent, chronic afib, moderate AS, COPD, Type II DM, who presented on 12/29/21 with acute hypoxic respiratory failure due to COVID-19. He was admitted to the medical floor on airborne precautions and was started on decadron,remdesivir and oxygen. The patient improved clinically, he was evaluated by Home 02 who recommended 2 liters of 02. Patient with Type II DM, A1c 7.3 on metformin as an outpt. Metformin was held on admission. Pt with hyperglycemia due to decadron use, lantus was started during this hospitalization. Patient declined to take insulin at discharge, stating that he would resume metformin. He is agreeable to checking fsbs 2XD ( steroids will not be continued post discharge).
Two very swollen lymph nodes in left arm pit; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 08Apr2021(at the age of 36-year-old) as a single dose for COVID-19 immunisation. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, the patient experienced two very swollen lymph nodes in left arm pit. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event two very swollen lymph nodes in left arm pit was not recovered at the time of the report.   No follow-up attempts are needed. No further information is expected.
Date Received: 10/11/17, approximately 10am. Date of reaction: 10/11/17. Time of first symptom onset: 3pm, 10/11/17. Type of reaction 3pm, same date:Rash consisting of 4 red patches noticed to right forearm, not itchy. Per employee, "they are almost gone as of 4pm today" (10/12/17). 6:40pm, same day: "Shiver, headache, dizziness", gone by morning. Therapies used by person: NYQUIL and ALEVE, which seemed to help.
redness speading outward from the injection site, warm to touch, pain. no fever,. No treatment at time of complain
o Patient with several complaints that started after receiving her Johnson&Johnson COVID vaccine 3 weeks ago. She has swelling in her medial malleolar area with negative calf tenderness or Homans' sign. Due to recent findings with Johnson&Johnson vaccine, will send patient for doppler testing to look for the presence of a clot. Her swelling could be due to mild injury while working in her garden or varicose veins.  o Will obtain CBC to evaluate platelets due to patient's concerns for recent vaccine.  o Other complaints that may be related to the vaccine (visual change and fluid area on shin) have now resolved. Discussed with patient that based on the vaccines being new, difficult to know what side effects may be seen, but she should continue to watch for changes and encouraged her to see an eye specialist for an eye check.  o Last vitamin D was normal and advised that no check necessary at this time and that she can take Vitamin D 1000-2000 units daily.
Information has been received from a physician concerning a 12 month old patient who was vaccinated with a dose of MMR and varicella.  Subsequently, the patient developed a measles like rash 12 days post vaccination.  Unspecified medical attention was sought.  The outcome was unspecified by the reporter.  No product quality complaint was involved.  Additional information has been requested.
Red, hot swelling to site of injection (DTaP) 3" to 4" circ. (L) arm.
This case was reported by a pharmacist via call center representative and described the occurrence of headache in a 73-year-old male patient who received SHINGRIX (batch number 37KL2, expiry date 12th February 2021) and (batch number 2453L, expiry date 12th February 2021) for prophylaxis. Concurrent medical conditions included transient ischemic attack (2 times). On 11th September 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On an unknown date, the dose was an unknown dose. In September 2018, less than a week after receiving SHINGRIX, the patient experienced headache. On an unknown date, the outcome of the headache was not recovered/not resolved. It was unknown if the reporter considered the headache to be related to SHINGRIX. Additional details were provided as follows: This case was previously not reported to anyone. This case was reported by the patient's wife. The patient received SHINGRIX in the left deltoid. The patient experienced tenderness on the left side of his head, it was tender to the touch, like he was hit. This had not gotten worse or improved till the time of reporting. It was stated that, the patient had not broken out and did not felt bad. The patient's wife planned to take the patient to the doctor office on the day of reporting.